NF-κB: tumor promoter or suppressor?
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Cell Biology
- Vol. 14 (2), 64-69
- https://doi.org/10.1016/j.tcb.2003.12.004
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Transcription factors as targets for cancer therapyNature Reviews Cancer, 2002
- NF-κB: arresting a major culprit in cancerDrug Discovery Today, 2002
- NF-κB in neuronal plasticity and neurodegenerative disordersJournal of Clinical Investigation, 2001
- NF-κB: pivotal mediator or innocent bystander in atherogenesis?Journal of Clinical Investigation, 2001
- Hostile takeovers: viral appropriation of the NF-kB pathwayJournal of Clinical Investigation, 2001
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockoutsOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997